Your browser doesn't support javascript.
loading
Ocoxin as a complement to first line treatments in cancer.
Benedicto, Aitor; Sanz, Eduardo; Márquez, Joana.
Affiliation
  • Benedicto A; Department of Cellular Biology and Histology, School of Medicine and Nursing, University of the Basque Country, 48940, Leioa, Bizkaia, Spain.
  • Sanz E; Catalysis S.L., Toledo, Spain.
  • Márquez J; Department of Cellular Biology and Histology, School of Medicine and Nursing, University of the Basque Country, 48940, Leioa, Bizkaia, Spain.
Int J Med Sci ; 18(3): 835-845, 2021.
Article in En | MEDLINE | ID: mdl-33437220
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Pantothenic Acid / Ascorbic Acid / Radiation Injuries / Vitamin B 12 / Plant Extracts / Antineoplastic Combined Chemotherapy Protocols / Zinc Sulfate / Vitamin B 6 / Drug-Related Side Effects and Adverse Reactions / Folic Acid Type of study: Etiology_studies Language: En Journal: Int J Med Sci Year: 2021 Type: Article Affiliation country: Spain
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Pantothenic Acid / Ascorbic Acid / Radiation Injuries / Vitamin B 12 / Plant Extracts / Antineoplastic Combined Chemotherapy Protocols / Zinc Sulfate / Vitamin B 6 / Drug-Related Side Effects and Adverse Reactions / Folic Acid Type of study: Etiology_studies Language: En Journal: Int J Med Sci Year: 2021 Type: Article Affiliation country: Spain